Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial

作者：Shankar Siva, Mathias Bressel, Mark A. Sidhom, Swetha Sridharan, Ben G. L. Vanneste, Ryan Davey, Rebecca Montgomery, Jeremy Ruben, Farshad Foroudi, Braden Higgs, Charles Lin, Avi Raman, Nicholas Hardcastle, Michael S. Hofman, Richard De Abreu Lourenço, Mark G. Shaw, Pascal Mancuso, DANIEL A. MOON, Lih‐Ming Wong, Nathan Lawrentschuk, Simon Wood, Nicholas R. Brook, Tomas Kron, Jarad M. Martin, David I. Pryor, Brent Chesson, Muhammad Ali, Sarat Chander, Alisha Moore, Olivia Cook, Thomas Eade, Harish Sharma, Muralidas Ramanathan, Kate Howe, Helen Frewen · 发表于：The Lancet Oncology · 年份：2024 · DOI：10.1016/s1470-2045(24)00020-2 · 被引用次数：120 · 研究领域：Renal cell carcinoma treatment、Bladder and Urothelial Cancer Treatments、Kidney Stones and Urolithiasis Treatments